- ►annals.org DG Maggs, TA Buchanan, CF Burant, G Cline, B … - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Troglitazone is a new insulin-sensitizing agent used to treat ... Cited by 267 - Related articles - BL Direct - All 6 versions
SE Inzucchi, DG Maggs, GR Spollett, SL Page, … - The New England journal of medicine, 1998 - nejm.highwire.org Results During metformin therapy, fasting and postprandial plasma glucose
concentrations decreased by 20 percent (58 mg per deciliter [3.2 mmol per
liter], P<0.001) and 25 percent (87 mg per deciliter [4.8 mmol per liter], ... Cited by 558 - Related articles - BL Direct - All 6 versions
Y Iwamoto, K Kosaka, T Kuzuya, Y Akanuma, … - Diabetes Care, 1996 - Am Diabetes Assoc OBJECTIVE: To investigate the clinical efficacy of troglitazone, a newly
developed oral hypoglycemic agent, in patients with NIDDM. RESEARCH DESIGN AND
METHODS: There were 284 NIDDM patients (20-82 years of age) whose glycemic ... Cited by 158 - Related articles - BL Direct - All 6 versions
SL Suter, JJ Nolan, P Wallace, B Gumbiner, … - Diabetes Care, 1992 - Am Diabetes Assoc OBJECTIVE--To study the metabolic effects of a new oral antidiabetic agent,
CS-045, in subjects with non-insulin-dependent diabetes mellitus (NIDDM).
RESEARCH DESIGN AND METHODS--Eleven NIDDM subjects (mean age 59 yr and body ... Cited by 362 - Related articles - All 5 versions
S Kumar, AJM Boulton, H Beck-Nielsen, F … - Diabetologia, 1996 - Springer Summary The effects of troglitazone, a novel thia- zolidinedione, in
non-insulin-dependent diabetic (NIDDM) patients were studied in a double-blind,
parallel-group, placebo-controlled, dose-ranging trial. A total of 330 ... Cited by 200 - Related articles - BL Direct - All 5 versions
- ►endojournals.org [PDF] VA Fonseca, TR Valiquett, SM Huang, MN … - Journal of Clinical Endocrinology & Metabolism, 1998 - Endocrine Soc ABSTRACT To assess the effects of troglitazone monotherapy on glycemic con- trol
in patients with type 2 diabetes mellitus, we carried out a 6-month, randomized,
double-blind, placebo-controlled study in 24 hospital and outpatient ... Cited by 93 - Related articles - BL Direct - All 6 versions
MN Ghazzi, JE Perez, TK Antonucci, JH … - Diabetes, 1997 - Am Diabetes Assoc Troglitazone is a thiazolidinedione under development for the treatment of NIDDM
and potentially other insulin-resistant disease states. Treatment with
troglitazone is associated with an improvement in hyperglycemia, ... Cited by 314 - Related articles - BL Direct - All 4 versions
S Schwartz, P Raskin, V Fonseca, JF … - New England Journal of Medicine, 1998 - content.nejm.org Methods We studied the effect of troglitazone or placebo in 350 patients with
poorly controlled non-insulin-dependent (type II) diabetes mellitus
(glycosylated hemoglobin values, 8 to 12 percent; normal, 4.3 to 6.1 ... Cited by 230 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org [PDF] ES Horton, F Whitehouse, MN Ghazzi, TC … - Diabetes Care, 1998 - Am Diabetes Assoc Type 2 diabetes is a chronic and pro- g ressive disease that affects more than
16 million people in the US, half of whom do not even know they have the disease
(1,2). The cost of tre ating diabetes and its long-term complications ( re ... Cited by 99 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] JP Frias, JG Yu, YT Kruszynska, JM Olefsky - Diabetes Care, 2000 - Am Diabetes Assoc Study subjects Nine type 2 diabetic, nine obese (BMI 26 kg/m2), and nine lean
subjects (BMI 26 kg/m2) were studied. Clinical charac- teristics are given in
Table 1. All were in good general health and had normal re nal and liver ... Cited by 45 - Related articles - BL Direct - All 4 versions
